Caissa Capital Management ltd. - Apr 10, 2023 Form 4 Insider Report for Avalo Therapeutics, Inc. (AVTX)

Role
10%+ Owner
Signature
Cambyz Golestaneh, Title: Director
Stock symbol
AVTX
Transactions as of
Apr 10, 2023
Transactions value $
$142,516
Form type
4
Date filed
4/11/2023, 04:51 PM
Next filing
Apr 18, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVTX Common Stock Purchase $71.4K +31.3K +2.59% $2.28 1.24M Apr 10, 2023 See Footnote (1) F1, F2
transaction AVTX Common Stock Purchase $71.1K +25K +2.01% $2.84* 1.27M Apr 11, 2023 See Footnote (1) F1, F3
holding AVTX Common Stock 182K Apr 10, 2023 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held by Caissa Capital Management Ltd, a British Virgin Islands company controlled by Mr. Golestaneh
F2 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.835 to $2.51, inclusive.
F3 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.41 to $3.225, inclusive.
F4 These shares are directly owned by Mr. Golestaneh in his personal capacity.